Divi's Labs Reports 18% Dip In Net Profit For The Sept Quarter, Consolidated Income At Rs 1,935 Cr

The pharma major Divi's Laboratories, has declared its quarterly earnings for the quarter that ended on 30th September 2022, the pharmaceutical giant has announced its consolidated revenue which stood at Rs 1,935 crores, a 3.5 per cent slump against the earnings of the corresponding quarter last year which stood at Rs 2,007 crores.

The company also registered an 18.48 per cent drop in its net profit in the second quarter to be recorded at Rs 494 crores as against its earnings in the same quarter last year which stood at Rs 606 crores.

The company said it has a forex gain of Rs 31 crores as against a loss of Rs 7 crores during the corresponding quarter of last year. 

The pharma major recorded slight positives in its year-on-year earnings, as the company's consolidated earnings registered a 6.5 per cent rise over last year's earnings at the halfway stage. The consolidated revenues for the half-year ended 30th September 2022 stood at Rs 4,278 crores as against a consolidated total income of Rs 3,996 crores during the previous half-year.

The company's PAT(Profit After Tax) also recorded a 2.6 per cent jump year on year at Rs 1,196 crore against Rs 1,164 crore recorded for the previous half-year.

The company's stock fell by 7.02 per cent to Rs 3,480 a piece by 13:44 Pm IST on Monday after the announcement of the quarterly results.